§ 13F · FUND PROFILE
Paradigm Biocapital Advisors LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 35Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$984M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | ACLX | ARCELLX INC | 5.77M | $663M | 13.5% | +1% |
| 2 | RVMD | REVOLUTION MEDICINES INC | 6.66M | $647M | 13.2% | ±0% |
| 3 | NUVL | NUVALENT INC | 5.32M | $545M | 11.1% | +1% |
| 4 | PCVX | VAXCYTE INC | 4.79M | $279M | 5.7% | +18% |
| 5 | EWTX | EDGEWISE THERAPEUTICS INC | 7.37M | $232M | 4.7% | +13% |
| 6 | GMAB | GENMAB A/S | 7.97M | $214M | 4.4% | +13% |
| 7 | INSM | INSMED INC | 1.25M | $205M | 4.2% | NEW |
| 8 | TARS | TARSUS PHARMACEUTICALS INC | 2.56M | $180M | 3.7% | ±0% |
| 9 | BLTE | BELITE BIO INC | 1.11M | $178M | 3.6% | NEW |
| 10 | ERAS | ERASCA INC | 10.39M | $168M | 3.4% | −27% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE PARADIGM SIGNAL
AC read
Paradigm Biocapital Advisors LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed